[ACTION OF MONOAMINE OXIDASE AND CATECHOL-AMINE OXIDASE ON HEPATIC ADRENALINOLYSIS AND GLYCOGENOLYSIS].
D001001:Anura; D004156:Catechol Oxidase; D002395:Catecholamines; D002396:Catechols; D050261:Glycogenolysis; D007490:Iproniazid; D008099:Liver / Q000201:enzymology* / Q000502:physiology*; D008112:Liver Glycogen; D008995:Monoamine Oxidase; D009526:Nialamide; D010088:Oxidoreductases; D010600:Pharmacology; D011748:Pyrogallol; D012106:Research; D014116:Toxicology
D002395:Catecholamines; D002396:Catechols; D008112:Liver Glycogen; D011748:Pyrogallol; D007490:Iproniazid; D010088:Oxidoreductases; D004156:Catechol Oxidase; D008995:Monoamine Oxidase; C034221:catechol; D009526:Nialamide
CATECHOLAMINES; EXPERIMENTAL LAB STUDY; IPRONIAZID; LIVER ENZYMOLOGY; LIVER FUNCTION; LIVER GLYCOGEN; MONOAMINE OXIDASE; NIALAMIDE; OXIDOREDUCTASES; PHARMACOLOGY; PYROGALLOL; TOADS; TOXICOLOGIC REPORT
ACTION DE LA MONOAMINEOXYDASE ET DE LA CAT'ECHOL-AMINEOXYDASE SUR L'ADR'ENALINOLYSE ET LA GLYCOG'ENOLYSE H'EPATIQUES.